CN104450612A - Method for separating and identifying human amniotic mesenchymal stem cells - Google Patents

Method for separating and identifying human amniotic mesenchymal stem cells Download PDF

Info

Publication number
CN104450612A
CN104450612A CN201410741509.1A CN201410741509A CN104450612A CN 104450612 A CN104450612 A CN 104450612A CN 201410741509 A CN201410741509 A CN 201410741509A CN 104450612 A CN104450612 A CN 104450612A
Authority
CN
China
Prior art keywords
cell
mesenchymal stem
separating
stem cells
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410741509.1A
Other languages
Chinese (zh)
Inventor
敖云霞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410741509.1A priority Critical patent/CN104450612A/en
Publication of CN104450612A publication Critical patent/CN104450612A/en
Pending legal-status Critical Current

Links

Abstract

The invention discloses a method for separating and identifying human amniotic mesenchymal stem cells. The method comprises the following steps: separating amniotic mesenchymal stem cells by adopting a tissue explants adherent method, and carrying out subculture; observing the cell form of cells from P1-P3 generations; detecting positive molecules and negative molecules on the surfaces of cell membranes by virtue of a flow cytometer and detecting the cell proliferation situation by adopting a six-pore plate method. According to the method, the cells separated from amniotic membrane tissues are hAMSCs, so that basis is provided to further studies on the hAMSCs in biological and immunological properties, differentiative capacity and karyotype stability and in serving as seed cells of clinical application and the like.

Description

A kind of Isolation and ldentification method of human amnion mesenchymal stem cell
Technical field
The present invention relates to a kind of Isolation and ldentification method of human amnion mesenchymal stem cell, belong to medical detection technology.
Background technology
Placenta combines by the embryophoric membrane of embryo and maternal uterine inner membrance the transitional organ exchanging material between the mothers and sons that grow up to, except containing except nurse cell, also containing a large amount of blood vessel and mesenchyme composition, placenta mesenchyma stem cell be in recent years newfound from placenta obtain a class stem cell, compared with the stem cell of extracting from Cord blood or marrow, not only stem cell population is many but also can be divided into the histocyte of multiple types, and placenta tissue derives from postpartum, it is collected process and is not caused any damage to parent and newborn infant, not by ethics and clinical medical restriction, in addition, researchist finds from Cell surface antigen analysis, placenta mesenchyma stem cell is the stem cell between embryonic stem cell and adult stem cell, due to its reduced immunogenicity, not easily repelled by the immunity system of acceptor, that desirable stem cell preserves and the structure of resource placenta that utilizes mainly haves three layers (amnion) chorion and decidua, blood vessel and red corpuscle are then rich in chorion and decidua, not easily separated, amnion is that one deck is easy to be separated, and structure simply organizes % if isolate mescenchymal stem cell from amnion, to be a good donor of mescenchymal stem cell, for investigator provides a simple pathway obtaining mescenchymal stem cell.
Summary of the invention
The object of the invention is: a kind of Isolation and ldentification method that human amnion mesenchymal stem cell is provided, human amnion mesenchymal stem cell can be gone out, to overcome the deficiencies in the prior art from from external successful separation and Culture.
Technical scheme of the present invention
A kind of Isolation and ldentification method of human amnion mesenchymal stem cell, tissue explants adherent method is adopted to isolate amnion mesenchymal stem cell and Secondary Culture, P1-P3 is carried out to the observation of cellular form for cell, adopt six well plate method to detect cell proliferative conditions with the positive molecule of flow cytomery surface of cell membrane and negative molecule.
Owing to adopting technique scheme; compared with prior art; the present invention by amnion tissue block is attached to culturing bottle carries out cultivation 7-10d after go out cell from tissue block surrounding growth; form of diverse; but based on spindle shape, after going down to posterity, growth rapidly, grows in flowing water shape; 3-6d reaches summit of growth, and this is consistent with the growth characteristics of bone marrow MSCs; Be passaged to for the 3rd generation, by flow cytometer detection cell membrane surface molecules, result display (cell high expression level CD44, CD105, CD73HE CD90, its phenotypic characteristic is similar to bone marrow MSCs; Illustrating that cell is isolated in this experiment from placenta amnion tissue is hAMSCs, for studying biology and immunological characteristic, differentiation capability, the karyotypic stability of hAMSCs further, and it can be used as the seed cell etc. of clinical application to provide the foundation.
Embodiment
The present invention is described in further detail below, but not as any limitation of the invention.
Embodiments of the invention:
1 materials and methods
1.1 Specimen origin
After placenta takes from health full term newborn infant Cesarean operation, contribute gained through family members' informed consent after signing " placenta processing protocol book ".
1.2 main raws and instrument
1.2.1 main raw
Permeability type Tissue Culture Flask (NEST), aseptic calibrated pipet, six orifice plates, centrifuge tube, bus obtain suction pipe, eye scissors, ophthalmic tweezers, operating scissors, penicillin bottle etc.
1.2.2 main agents
Cell culture fluid is that L-DMEM adds 10%FBS, 0.25% trypsinase, 5.5%NaHCO 3, green grass or young crops-chain enzyme mixed solution etc.
1.2.3 key instrument equipment
Bechtop (Suzhou purification) CO2 cell culture incubator, flow cytometer, inverted microscope, cryogenic freezing whizzer, just put microscope etc.
1.3 method
1.3.1 hAMSCs separation and Culture
Under aseptic condition, the placenta near umbilical cord place is cut, careful denuded amniotic membrane, and with stroke-physiological saline solution (NS) cleaning for several times until liquid is limpid, transfer them in penicillin bottle and be cut into about 1-2cm size with eye scissors, be laid in 25cm2 Tissue Culture Flask with ophthalmic tweezers gripping, carefully add nutrient solution along culturing bottle wall, make nutrient solution can cover amnion tissue block, be unlikely to again to make it floating, finally culturing bottle be placed in 37 degree of 5%CO2 incubators and cultivate.
1.3.2 hAMSCs Secondary Culture
After seeing and having Growth of Cells around tissue block, every 2d changes liquid 1 time, and when cell grows in the form of sheets, available aseptic PSB washes away amnion tissue block; After this, the next day change liquid 1 time, can go down to posterity when cell grows up to individual layer; First wash with aseptic PSB liquid when going down to posterity; After time, to remove residual nutrient solution, then use 0.25% trypsin solution (about 1.5ml) to digest about 3min in 37 degree, nutrient solution stops digestion, carefully blowing and beating cell with bus moral suction pipe makes it come off from culturing bottle, be transferred in 15min centrifuge tube, the centrifugal 3min of 800r/min, abandons supernatant, precipitation nutrient solution is resuspended, in evenly distribute to 2 culturing bottle, be placed in 37 degree of 5%CO2 incubators and cultivate, next day changes liquid.
1.3.3 hAMSCs phenotypic evaluation
The cell being passaged to P3 generation will be separated, according to flow cytometer detection test kit operation instruction and step operation, use flow cytomery cell membrane surface molecules, the positive molecule of detection comprises CD73-AP, CD90-FITC, CD105-Cy5.5 and negative molecule comprises CD11b-PE, CD19-PE, CD34-PE, CD45-PE, HLA-DR-PE.
The experiment 1.3.4 hAMSCs rises in value
The cell adopting six well plate method to detect cell proliferative conditions P3 generation is inoculated in six orifice plates, every porocyte quantity 1*10 3, be placed in 37 degree of 5%CO2 incubators and cultivate, the next day change liquid 1 time, grow up to until cell and get every day after individual layer, porocyte carries out tire and expects blue dyeing, with cell counting count board living cell counting number, and draws growth curve.
The present invention by amnion tissue block is attached to culturing bottle carries out cultivation 7-10d after go out cell from tissue block surrounding growth, form of diverse, but based on spindle shape; after going down to posterity, growth rapidly; grow in flowing water shape, 3-6d reaches summit of growth, and this is consistent with the growth characteristics of bone marrow MSCs; Be passaged to for the 3rd generation, by flow cytometer detection cell membrane surface molecules, result display (cell high expression level CD44, CD105, CD73HE CD90, its phenotypic characteristic is similar to bone marrow MSCs; Illustrating that cell is isolated in this experiment from placenta amnion tissue is hAMSCs, for studying biology and immunological characteristic, differentiation capability, the karyotypic stability of hAMSCs further, and it can be used as the seed cell etc. of clinical application to provide the foundation.

Claims (1)

1. the Isolation and ldentification method of a human amnion mesenchymal stem cell, it is characterized in that: adopt tissue explants adherent method to isolate amnion mesenchymal stem cell and Secondary Culture, P1-P3 is carried out to the observation of cellular form for cell, adopt six well plate method to detect cell proliferative conditions with the positive molecule of flow cytomery surface of cell membrane and negative molecule.
CN201410741509.1A 2014-12-08 2014-12-08 Method for separating and identifying human amniotic mesenchymal stem cells Pending CN104450612A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410741509.1A CN104450612A (en) 2014-12-08 2014-12-08 Method for separating and identifying human amniotic mesenchymal stem cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410741509.1A CN104450612A (en) 2014-12-08 2014-12-08 Method for separating and identifying human amniotic mesenchymal stem cells

Publications (1)

Publication Number Publication Date
CN104450612A true CN104450612A (en) 2015-03-25

Family

ID=52897371

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410741509.1A Pending CN104450612A (en) 2014-12-08 2014-12-08 Method for separating and identifying human amniotic mesenchymal stem cells

Country Status (1)

Country Link
CN (1) CN104450612A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106754674A (en) * 2016-12-09 2017-05-31 博雅干细胞科技有限公司 Method and its application of amnion mesenchymal stem cell are prepared from Human plactnta amnion
CN109652362A (en) * 2017-10-12 2019-04-19 北京弘润天源基因生物技术有限公司 A kind of method that umbilical cord film saves and prepares stem cell

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106754674A (en) * 2016-12-09 2017-05-31 博雅干细胞科技有限公司 Method and its application of amnion mesenchymal stem cell are prepared from Human plactnta amnion
CN106754674B (en) * 2016-12-09 2019-09-20 博雅干细胞科技有限公司 The method and its application of amnion mesenchymal stem cell are prepared from Human plactnta amnion
CN109652362A (en) * 2017-10-12 2019-04-19 北京弘润天源基因生物技术有限公司 A kind of method that umbilical cord film saves and prepares stem cell

Similar Documents

Publication Publication Date Title
CN109880797A (en) A method of preparing human umbilical cord mesenchymal stem cells excretion body
JP5179376B2 (en) In vitro growth of postpartum-extracted cells in roller bottles
CN106754674B (en) The method and its application of amnion mesenchymal stem cell are prepared from Human plactnta amnion
CN105950550A (en) Mesenchymal stem cell serum-free medium and cell isolation and cultivation methods
CN107746829B (en) Method for separating and primary culturing dog placenta-derived mesenchymal stem cells
CN105420179A (en) Method for simultaneously extracting epithelial cells and mesenchymal stem cells from umbilical cord and placenta amnion tissues
CN104450611A (en) Primary separation and culture method of human amniotic mesenchymal stem cells
CN103525752B (en) Separation and purification method of goat mammary epithelial cells
CN104818244B (en) A kind of amniotic epithelial cells separation, the method for culture
CN106318906A (en) Method for large-scale culture of human umbilical cord mesenchymal stem cells
CN105420185A (en) Method for separating and extracting hUC-MSC from umbilical cord outer layer amnion tissue
CN107354130A (en) A kind of intermembranous mesenchymal stem cells separation method of human placenia
CN104450612A (en) Method for separating and identifying human amniotic mesenchymal stem cells
CN104974980A (en) Human amniotic epithelial cell separation method
CN107236705B (en) Human placenta chorion mesenchymal stem cell culture system
CN103484424B (en) Single cell cloning method for obtaining goat mammary epithetical cells
CN108865988A (en) A kind of separation of human amnion mesenchymal stem cell, culture and purification process
CN104830764A (en) Primary isolated culture method for amniotic fluid mesenchymal stem cells
CN105112359A (en) Separating and cultivating method of mouse umbilical cord mesenchymal stem cells
CN105062960B (en) Primary isolation and culture method of periodontal ligament stem cells
Kusuma et al. Derivation of endothelial cells and pericytes from human pluripotent stem cells
CN106635980B (en) A kind of the sheep derived from peripheral blood cell line and its method for building up of spontaneous immortalization
CN110184236A (en) A kind of preparation method of amnion mesenchymal stem cell
CN102041243A (en) Kit and method for fast separating bone marrow mesenchymal stem cells
CN105624115B (en) Culture medium for inducing human umbilical cord mesenchymal stem cells to differentiate into nerve-like cells and induction method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150325

WD01 Invention patent application deemed withdrawn after publication